Cancer Gene Therapy Market Size to Surpass US$ 8.33 billion by 2031 - Growth Plus Reports

Pune, Feb. 06, 2024 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Cancer Gene Therapy Market is expected to clock US$ 8.33 billion by 2031 and to grow at a CAGR of 19.8% during the forecast period.

The global Cancer Gene Therapy Market is experiencing profound growth, driven by groundbreaking advancements in genetic engineering, increasing understanding of cancer biology, and the growing demand for personalized cancer treatments. A comprehensive analysis of the market reveals a dynamic landscape dedicated to revolutionizing cancer care and improving patient outcomes.

Get a Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/cancer-gene-therapy-market/8450

Cancer Gene Therapy Market Scope

Market Overview:
Cancer gene therapy involves the use of genetically engineered vectors to deliver therapeutic genes into cancer cells, with the aim of inhibiting tumor growth, inducing apoptosis, or triggering immune responses against cancerous cells. The Cancer Gene Therapy Market is witnessing robust expansion as researchers and biopharmaceutical companies explore the potential of gene-based therapies to address the complexities of cancer and overcome treatment resistance.

Key Market Drivers:

1. Advancements in Genetic Engineering: Ongoing advancements in genetic engineering technologies, such as viral vectors, non-viral vectors, and gene editing tools like CRISPR-Cas9, are driving innovation in cancer gene therapy. These technologies enable precise targeting of cancer cells, minimizing off-target effects and enhancing the efficacy of therapeutic interventions.

2. Personalized Cancer Treatments: The paradigm shift towards personalized medicine in oncology is fuelling the demand for cancer gene therapy. By targeting specific genetic mutations or alterations driving tumor growth, gene-based therapies offer a tailored approach to cancer treatment, maximizing therapeutic benefits while minimizing adverse effects on healthy tissues.

3. Emerging Immunotherapy Approaches: Cancer gene therapy intersects with immunotherapy, harnessing the body's immune system to recognize and eliminate cancer cells. Engineered gene therapies, such as chimeric antigen receptor (CAR) T-cell therapy and oncolytic viruses, show promise in enhancing immune responses against tumors and overcoming immune evasion mechanisms employed by cancer cells.

Competitive Landscape:
The global Cancer Gene Therapy market features a competitive landscape with key players contributing to research, development, and commercialization of gene-based therapies. The report profiles major companies, offering insights into their product pipelines, clinical trials, strategic partnerships, and recent innovations.

Challenges and Opportunities:
While the Cancer Gene Therapy Market presents significant opportunities, challenges such as optimizing delivery mechanisms, ensuring safety and efficacy of gene-based therapies, and navigating regulatory complexities need to be addressed. However, ongoing research, collaborative efforts across academia and industry, and the potential for combination therapies offer avenues for growth and innovation.

Table of Content

1. INTRODUCTION

1. 1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report

2. RESEARCH METHODOLOGY 

2. 1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions

3. PREMIUM INSIGHTS

3. 1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022)
   3. Regulatory Landscape

4. MARKET DYNAMICS

4. 1. Drivers
   2. Restraints/Challenges
   3. Opportunities

5. GLOBAL CANCER GENE THERAPY MARKET - ANALYSIS & FORECAST, BY THERAPY TYPE

5. 1. Gene-Induced Immunotherapy
   2. Gene Transfer
   3. Oncolytic Virotherapy

6. GLOBAL CANCER GENE THERAPY MARKET - ANALYSIS & FORECAST, BY INDICATION

6. 1. Lung Cancer
   2. Prostate Cancer
   3. Breast Cancer
   4. Pancreatic Cancer
   5. Others

7. GLOBAL CANCER GENE THERAPY MARKET - ANALYSIS & FORECAST, BY END-USER

7. 1. Academic & Research Institutes
   2. Biopharmaceutical Companies 
   3. Others

Browse full TOC here

Future Outlook:
The report provides a forward-looking perspective on the Cancer Gene Therapy market, offering insights into potential growth opportunities, emerging trends, and factors that could shape the market in the coming years. With a focus on advancing precision medicine approaches and harnessing the power of genetic engineering to combat cancer, the global market is poised for continued innovation and transformative impact on oncology care.

In conclusion, the report serves as a valuable resource for industry stakeholders, providing a comprehensive analysis of market trends, challenges, and opportunities. As cancer gene therapy continues to evolve as a promising frontier in oncology, it holds the potential to redefine treatment standards and improve survival outcomes for cancer patients worldwide.

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• 'Business Profile' of Key Players

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8450

Browse other reports:

According to the deep-dive market assessment study by Growth Plus Reports, the global personal emergency response system market was valued at US$ 5.84 billion in 2022 and is expected to register a revenue CAGR of 5.8% to reach US$ 9.70 billion by 2031.

According to the deep-dive market assessment study by Growth Plus Reports, the global phenylketonuria market was valued at US$ 592.9 million in 2022 and is expected to register a revenue CAGR of 12.4% to reach US$ 1,697.7 million by 2031. 

According to the deep-dive market assessment study by Growth Plus Reports, the global vascular plugs market was valued at US$ 117 million in 2022 and is expected to register a revenue CAGR of 5.8% to reach US$ 195.9 million by 2031.

According to the deep-dive market assessment study by Growth Plus Reports, the global veterinary antibiotics market was valued at US$ 4.76 billion in 2023 and is expected to register a revenue CAGR of 3.40% to reach US$ 6.23 billion by 2031.

According to the deep-dive market assessment study by Growth Plus Reports, the global drug-eluting balloon catheters market was valued at US$ 540 million in 2022 and is expected to register a revenue CAGR of 8.2% to reach US$ 1097 million by 2031.

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as Most Innovative Healthcare Market Research Company in 2020.